SE9500148D0 - Antibodies for use in cancer therapy and diagnosis - Google Patents

Antibodies for use in cancer therapy and diagnosis

Info

Publication number
SE9500148D0
SE9500148D0 SE9500148A SE9500148A SE9500148D0 SE 9500148 D0 SE9500148 D0 SE 9500148D0 SE 9500148 A SE9500148 A SE 9500148A SE 9500148 A SE9500148 A SE 9500148A SE 9500148 D0 SE9500148 D0 SE 9500148D0
Authority
SE
Sweden
Prior art keywords
diagnosis
cancer
antibody
antibodies
therapy
Prior art date
Application number
SE9500148A
Other languages
English (en)
Inventor
Roland Carlsson
Bo Jansson
Original Assignee
Bioinvent Internatioal Ab
Pronova As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioinvent Internatioal Ab, Pronova As filed Critical Bioinvent Internatioal Ab
Priority to SE9500148A priority Critical patent/SE9500148D0/sv
Publication of SE9500148D0 publication Critical patent/SE9500148D0/sv
Priority to AU44991/96A priority patent/AU4499196A/en
Priority to PCT/SE1996/000029 priority patent/WO1996022310A1/en

Links

SE9500148A 1995-01-18 1995-01-18 Antibodies for use in cancer therapy and diagnosis SE9500148D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9500148A SE9500148D0 (sv) 1995-01-18 1995-01-18 Antibodies for use in cancer therapy and diagnosis
AU44991/96A AU4499196A (en) 1995-01-18 1996-01-15 Antibodies for use in cancer therapy and diagnosis
PCT/SE1996/000029 WO1996022310A1 (en) 1995-01-18 1996-01-15 Antibodies for use in cancer therapy and diagnosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500148A SE9500148D0 (sv) 1995-01-18 1995-01-18 Antibodies for use in cancer therapy and diagnosis

Publications (1)

Publication Number Publication Date
SE9500148D0 true SE9500148D0 (sv) 1995-01-18

Family

ID=20396855

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9500148A SE9500148D0 (sv) 1995-01-18 1995-01-18 Antibodies for use in cancer therapy and diagnosis

Country Status (3)

Country Link
AU (1) AU4499196A (sv)
SE (1) SE9500148D0 (sv)
WO (1) WO1996022310A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10016877A1 (de) 2000-04-05 2001-10-18 Scintec Diagnostics Gmbh Zug (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK172686A (da) * 1985-04-22 1986-10-23 Hybritech Inc Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
JPS63157995A (ja) * 1986-12-18 1988-06-30 Kyowa Hakko Kogyo Co Ltd 抗ヒト大腸癌単クロ−ン性抗体ａｃｃ−５７４
US4892933A (en) * 1988-04-20 1990-01-09 New England Deaconess Hospital Corporation Monoclonal antibody for colorectal carcinoma
DE69029270T2 (de) * 1989-09-15 1997-03-27 Genetic Systems Corp HYBRIDOMA CT43, DAS EIN ANTIKöRPER GEGEN EIN MUCINEPITOP VON DARMKREBS ERZEUGT
EP0519866A1 (en) * 1991-06-18 1992-12-23 Ciba-Geigy Ag Novel anti-HIV antibodies
ZA936260B (en) * 1992-09-09 1994-03-18 Smithkline Beecham Corp Novel antibodies for conferring passive immunity against infection by a pathogen in man
WO1994012214A1 (en) * 1992-12-01 1994-06-09 Protein Design Labs, Inc. Humanized antibodies reactive with cd18

Also Published As

Publication number Publication date
AU4499196A (en) 1996-08-07
WO1996022310A1 (en) 1996-07-25

Similar Documents

Publication Publication Date Title
IL148113A0 (en) Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
NZ337413A (en) Antibodies that bind to Prostate Stem Cell Antigen (PSCA) to treat prostate cancer.
MY108519A (en) Novel antibodies reactive with human carcinomas.
AU2555297A (en) Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
DE69434286D1 (de) Immunologische bestimmungen von prostata-spezifischem antigen
DE69734109D1 (de) Humanisierung von anti-carcinoembryonalen Antigen anti-idiotypischen Antikörper und dessen Verwendung als Tumorvakzin und zur Markierung
HK1020990A1 (en) Antibodies to the ed-b domain of fibronectin, their construction and uses
HUP9901562A2 (hu) Anti-CEA monoklonális antitestek, az ezeket tartalmazó konjugátumok és ezek felhasználása antitest irányított enzimes előgyógyszer terápiában
ZA945364B (en) Antibodies specific for human prostate glandular kallikrein
DE3854581T2 (de) Antigen sf-25 des darm-adenokarzinoms sowie antikörper, die dieses antigen erkennen.
EP0352722A3 (en) Adenocarcinoma antigen binding methods and reagents
IL187595A (en) Pharmaceutical preparation containing monoclonal antibody - tumors and production
CA2036814A1 (en) Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof
CA2163868A1 (en) Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
AU2911289A (en) Carcinoma-associated antigens, and antibodies which recognize these antigens
SE9500148D0 (sv) Antibodies for use in cancer therapy and diagnosis
WO2004113388A3 (en) Anti alpha - folate - receptor - tetramer antibodies
NO20004251L (no) Humaniserte anti-CEA monoklonale antistoffer med høy affinitet
ATE288960T1 (de) Humanisierte monoklonale antikörper mit hoher affinität gegen tag-72
SE9501302D0 (sv) Antibodies for use in cancertherapy and diagnosis
EP0234501A3 (en) Monocional antibodies and methods for fungal pathogen detection
WO2002094194A3 (en) Compositions and methods for inhibiting metastasis
BR0007827A (pt) Anticorpos e fragmento fv que reconhecemantìgeno ior c2
WO2022015716A3 (en) Novel anti-pd1 antibodies for inhibiting t-cell activity
Hakalahti Generation and processing of monoclonal antibodies for applications in the diagnosis of prostatic cancer.